Scientists Warn Current Vitamin B12 Guidelines May Put Aging Brains at Risk
Research from UC San Francisco suggests that "normal" B12 levels may not be sufficient to protect against cognitive decline and brain damage in older adults.
Getting enough vitamin B12 to meet current health guidelines may not actually provide adequate protection for the aging brain, according to new research from the University of California, San Francisco. Researchers found that older adults with "normal" but lower levels of active B12 showed signs of slower thinking, delayed visual processing, and more damage to the brain's white matter—the critical communication highways that help different brain regions work together effectively.
The study, published in Annals of Neurology, examined 231 healthy participants through the Brain Aging Network for Cognitive Health (BrANCH) study at UCSF. The participants had an average age of 71 years and none had been diagnosed with dementia or mild cognitive impairment. Remarkably, their average blood B12 level was 414.8 pmol/L, significantly above the U.S. minimum cutoff of 148 pmol/L used to define deficiency, yet neurological problems were still apparent in those with lower levels within the normal range.
Senior author Dr. Ari J. Green from the UCSF Departments of Neurology and Ophthalmology noted that previous studies defining healthy B12 amounts may have missed subtle functional changes affecting people without causing obvious symptoms. The research team focused on the biologically active form of vitamin B12 rather than total B12 levels, which may better reflect how much of the vitamin the body can actually utilize for essential neurological functions.
Brain MRI scans revealed a concerning pattern among study participants with lower active B12 levels. After adjusting for age, sex, education, and cardiovascular risk factors, these individuals showed higher volumes of white matter lesions—areas of brain injury that have been linked to increased risks of cognitive decline, dementia, and stroke. The cognitive testing also demonstrated slower processing speeds and delayed responses to visual stimuli, indicating reduced brain signaling efficiency.
The findings suggest that current B12 deficiency thresholds may be inadequate for protecting brain health in aging populations. Dr. Green emphasized that revisiting the definition of B12 deficiency to incorporate functional biomarkers could enable earlier intervention and prevention of cognitive decline. The research highlights the importance of maintaining optimal rather than merely adequate B12 levels as people age, particularly given the vitamin's crucial role in DNA synthesis, red blood cell formation, and healthy nerve tissue maintenance.
